Willoughby Scott B. bought SGMO
April 1, 2026 · Form 4 insider transaction
Willoughby Scott B. bought 800,000 shares of Sangamo Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
800,000
Price
$0.00
Total value
N/A
InsiderWilloughby Scott B.
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after800,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One-quarter (1/4) of the shares subject to the option will vest and become exercisable on the first anniversary of the grant date, and the remainder of the shares will vest and become exercisable in 24 successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.